CONMED Corp. (CNMD)

39.46 -0.27 (-0.68%) USD  |  NYSE  |  Apr 15, 16:00
39.46 0.00 (0.00%) After-Hours: 20:00
More

CONMED Research and Development Expense (Annual) : 55.88M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CNMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Escalon Medical Corp. 0.7531M
IRIDEX Corp. 3.396M
Electromed, Inc. 0.996M
Guided Therapeutics, Inc. 0.469M
Axogen, Inc. 32.88M